Published in Arch Gen Psychiatry on August 01, 2006
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry (2009) 2.46
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry (2010) 1.96
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav (2012) 1.88
Hearing loss and cognition among older adults in the United States. J Gerontol A Biol Sci Med Sci (2011) 1.87
Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect (2008) 1.87
Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage (2009) 1.85
Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology (2009) 1.69
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment. Alzheimers Res Ther (2013) 1.62
Differential FDDNP PET patterns in nondemented middle-aged and older adults. Am J Geriatr Psychiatry (2009) 1.62
Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging (2008) 1.49
Heterogeneity of cognitive trajectories in diverse older persons. Psychol Aging (2010) 1.44
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology (2008) 1.41
Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain (2010) 1.35
Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev (2008) 1.35
Prediction of dementia in primary care patients. PLoS One (2011) 1.25
Selectivity of executive function deficits in mild cognitive impairment. Neuropsychology (2009) 1.24
Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period. Dement Geriatr Cogn Disord (2009) 1.22
Hormone therapy and cognitive function. Hum Reprod Update (2009) 1.22
Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology (2009) 1.20
Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol (2009) 1.17
Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study. J Am Geriatr Soc (2007) 1.16
Everyday functioning in mild cognitive impairment and its relationship with executive cognition. Int J Geriatr Psychiatry (2010) 1.14
Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry (2012) 1.13
Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial. BMC Neurol (2012) 1.13
Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging (2008) 1.10
Executive deficits are related to the inferior frontal junction in early dementia. Brain (2011) 1.09
Changes in cognition. Neurobiol Aging (2011) 1.06
Neuropsychological strategies for detecting early dementia. J Int Neuropsychol Soc (2008) 1.06
Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm. J Neurol (2009) 1.06
Mild cognitive dysfunction: an epidemiological perspective with an emphasis on African Americans. J Geriatr Psychiatry Neurol (2007) 1.06
MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage (2012) 1.02
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging Ment Health (2009) 1.02
Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it. Neurology (2013) 1.02
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry (2008) 1.01
Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol (2010) 0.99
Specific measures of executive function predict cognitive decline in older adults. J Int Neuropsychol Soc (2011) 0.98
Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study. PLoS One (2012) 0.98
Children of persons with Alzheimer disease: what does the future hold? Alzheimer Dis Assoc Disord (2008) 0.97
Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis. J Gerontol A Biol Sci Med Sci (2014) 0.97
Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurol (2011) 0.94
Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol (2011) 0.94
Cardiorespiratory fitness and cognitive function in middle age: the CARDIA study. Neurology (2014) 0.93
Are subjective cognitive complaints a risk factor for dementia? Neurol Sci (2010) 0.93
Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol (2009) 0.92
Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 0.92
Sparse temporally dynamic resting-state functional connectivity networks for early MCI identification. Brain Imaging Behav (2016) 0.91
For debate: substituting placebo controls in long-term Alzheimer's prevention trials. Alzheimers Res Ther (2011) 0.91
Patterns of word-list generation in mild cognitive impairment and Alzheimer's disease. Clin Neuropsychol (2009) 0.90
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. Int J Geriatr Psychiatry (2009) 0.90
A behavioral task predicts conversion to mild cognitive impairment and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.90
Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc (2009) 0.89
Demyelination in mild cognitive impairment suggests progression path to Alzheimer's disease. PLoS One (2013) 0.88
Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis (2011) 0.87
Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm (Vienna) (2009) 0.87
A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis (2012) 0.87
A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease. Int J Alzheimers Dis (2012) 0.87
Cognitive Dimensions in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common Metric. Open Geriatr Med J (2010) 0.86
Association of structural global brain network properties with intelligence in normal aging. PLoS One (2014) 0.86
Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis (2012) 0.86
Executive Dysfunction in MCI: Subtype or Early Symptom. Int J Alzheimers Dis (2012) 0.85
Old worries and new anxieties: behavioral symptoms and mild cognitive impairment in a population study. Am J Geriatr Psychiatry (2013) 0.85
Cognitive test performance predicts change in functional status at the population level: the MYHAT Project. J Int Neuropsychol Soc (2010) 0.84
Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation. BMC Neurosci (2011) 0.84
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage. Front Aging Neurosci (2013) 0.84
Defining MCI in the Framingham Heart Study Offspring: education versus WRAT-based norms. Alzheimer Dis Assoc Disord (2013) 0.83
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr Psychiatry (2010) 0.83
Early neuropsychological detection of Alzheimer's disease. Eur J Clin Nutr (2014) 0.83
Combining olfaction and cognition measures to screen for mild cognitive impairment. Neuropsychiatr Dis Treat (2006) 0.81
MEG spectral analysis in subtypes of mild cognitive impairment. Age (Dordr) (2014) 0.81
BFLCRM: A BAYESIAN FUNCTIONAL LINEAR COX REGRESSION MODEL FOR PREDICTING TIME TO CONVERSION TO ALZHEIMER'S DISEASE. Ann Appl Stat (2015) 0.80
Long-term intake of nuts in relation to cognitive function in older women. J Nutr Health Aging (2014) 0.80
Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment. Dement Geriatr Cogn Disord (2010) 0.80
Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center. J Alzheimers Dis (2013) 0.80
Lead exposure and rate of change in cognitive function in older women. Environ Res (2014) 0.80
Embedded Online Questionnaire Measures Are Sensitive to Identifying Mild Cognitive Impairment. Alzheimer Dis Assoc Disord (2016) 0.79
Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's disease. Arch Clin Neuropsychol (2013) 0.79
The Multiple Features Target Cancellation (MFTC): an attentional visual conjunction search test. Normative values for the Italian population. Neurol Sci (2012) 0.79
Short-Term Practice Effects and Brain Hypometabolism: Preliminary Data from an FDG PET Study. Arch Clin Neuropsychol (2015) 0.78
Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease. Cortex (2014) 0.78
Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment. J Alzheimers Dis (2014) 0.78
The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study. Dement Geriatr Cogn Dis Extra (2014) 0.78
Caregivers in China: knowledge of mild cognitive impairment. PLoS One (2013) 0.78
Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial. Contemp Clin Trials (2012) 0.78
Cognitive impairment in older adults without dementia: clinical and pathologic outcomes in a community-based sample. J Geriatr Psychiatry Neurol (2009) 0.77
Cognitive activities and instrumental activity of daily living in older adults with mild cognitive impairment. Dement Geriatr Cogn Dis Extra (2013) 0.77
Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease. Dement Geriatr Cogn Disord (2014) 0.77
Diagnostic tests for Alzheimer's disease: rationale, methodology, and challenges. Int J Alzheimers Dis (2010) 0.77
Family history of Alzheimer's disease limits improvement in cognitive function after bariatric surgery. SAGE Open Med (2014) 0.77
Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment. J Alzheimers Dis (2015) 0.77
Analysis of spatio-temporal brain imaging patterns by Hidden Markov Models and serial MRI images. Hum Brain Mapp (2014) 0.76
Patients with mild cognitive impairment have an abnormal upper-alpha event-related desynchronization/synchronization (ERD/ERS) during a task of temporal attention. J Neural Transm (Vienna) (2014) 0.76
The Walking Trail-Making Test is an early detection tool for mild cognitive impairment. Clin Interv Aging (2014) 0.76
Cognitive Function and Quality of Life in Community-Dwelling Seniors with Mild Cognitive Impairment in Taiwan. Community Ment Health J (2016) 0.76
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect (2004) 5.19
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2012) 4.22
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99
Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc (2002) 3.83
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med (1993) 3.45
Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect (2006) 3.42
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry (2002) 2.56
Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol (2004) 2.55
Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect (2006) 2.50
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol (2011) 2.44
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr (2006) 2.41
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Cognitive reserve and lifestyle. J Clin Exp Neuropsychol (2003) 2.27
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep (2004) 2.03
Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect (2005) 1.97
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92
Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr (2007) 1.91
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Age-related changes in brain activation during a delayed item recognition task. Neurobiol Aging (2006) 1.87
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh. Environ Health Perspect (2009) 1.83
Arsenic and manganese exposure and children's intellectual function. Neurotoxicology (2011) 1.82
An event-related fMRI study of the neurobehavioral impact of sleep deprivation on performance of a delayed-match-to-sample task. Brain Res Cogn Brain Res (2004) 1.80
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr (2005) 1.74
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Cognition assessment using the NIH Toolbox. Neurology (2013) 1.73
Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985) (2005) 1.73
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol (1990) 1.71
Folic acid supplementation lowers blood arsenic. Am J Clin Nutr (2007) 1.70
Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal study. J Int Neuropsychol Soc (2011) 1.66
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
I. NIH Toolbox Cognition Battery (CB): introduction and pediatric data. Monogr Soc Res Child Dev (2013) 1.61
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychol Rev (2008) 1.59
Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry (1996) 1.56
Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci (2013) 1.54
The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry (1996) 1.53
White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol Aging (2009) 1.52
Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord (2002) 1.52
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50
Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab (2007) 1.50
Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect (2007) 1.49
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49
No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect (2010) 1.48
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48